[ad_1] Viking Therapeutics Inc., the clinical-stage biotech that wowed investors this week with promising data…
Tag:
new product
-
-
STOCK MARKET
Viking Therapeutics’ weight-loss drug data makes company takeover target
by userby user[ad_1] Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to…
-
STOCK MARKET
Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results…
-
[ad_1] RAPT Therapeutics Inc. shares RAPT, +1.68% dropped more than 60% premarket on Tuesday after…
-
STOCK MARKET
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the…
-
STOCK MARKET
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
by userby user[ad_1] French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development…
-
[ad_1] Moderna Inc.’s stock soared 14% early Thursday after the biotech company and partner Merck…
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
-
STOCK MARKET
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
by userby user[ad_1] Bayer lost a fifth of its market value at one point Monday, after the…